Mitral stenosis screening: Difference between revisions
Created page with "__NOTOC__ {{Mitral stenosis}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [g..." |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended every [duration] among patients with signs or symptoms. | |||
According to the | |||
==Screening== | ==Screening== | ||
Exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate the response of the mean mitral gradient and pulmonary artery pressure in patients with MS when there is a discrepancy between resting Doppler echocardiographic findings and clinical symptoms or signs. | |||
OR | OR | ||
According to the | According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended every [duration] among patients with signs or symptoms. | ||
*[Condition 1] | *[Condition 1] | ||
*[Condition 2] | *[Condition 2] | ||
Revision as of 20:05, 10 March 2020
|
Mitral Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mitral stenosis screening On the Web |
|
American Roentgen Ray Society Images of Mitral stenosis screening |
|
Risk calculators and risk factors for Mitral stenosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended every [duration] among patients with signs or symptoms.
Screening
Exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate the response of the mean mitral gradient and pulmonary artery pressure in patients with MS when there is a discrepancy between resting Doppler echocardiographic findings and clinical symptoms or signs.
OR
According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended every [duration] among patients with signs or symptoms.
- [Condition 1]
- [Condition 2]
- [Condition 3]